Today we would like to introduce to Let's Talk Recovery (LKRV) a socially responsible microcap that manages two upscale boutique treatment and recovery facilities.

With a share price currently of $0.024, LKRV looks to be an exceptional opportunity for the aggressive microcap investor.

To learn more about LKRV visit the complete profile here

Let's Talk Recovery (LKRV)

A Socially Responsible Microcap

Website: http://www.letstalkrecovery.com

A special situation microcap offering socially responsible solutions to the highly fragmented drug and alcohol recovery community

Overview

Let's Talk Recovery (LKRV) is a socially responsible company dedicated to addressing the needs of alcoholism, various addictions, and obsessive behaviors. LKRV provides recovery programs, thought leadership through communications, educational programs, and corporate services for those affected by addiction as well as companies engaged in the recovery business.

LKRV currently manages two upscale boutique treatment and recovery facilities for clients seeking rehabilitation. Both locations offer qualified staff with tranquil settings designed to help clients overcome their addiction(s). LKRV recently signed an agreement with the Hythiam Corporation to license their proprietary pharmaceutical treatment for substance dependency, Prometa, for use at LKRV’s Laguna Beach Recovery Center.

The Company also owns and operates the Let's Talk Recovery Radio Network, a network of talk-radio shows focused on addition and recovery. Their programs are broadcasted globally via LIVE365.com to a rapidly growing listener base. Recently, LKRV Radio hosts were featured on CNN's " ShowBiz Tonight" as well as CBS "The Insider" discussing the inspirational and entertaining LKRV Radio Network.

LKRV Investor Highlights

• LKRV announced that first quarter revenues from operation of their Recovery Services Group grew over 110% as compared to the previous quarter.
• LKRV expects to generate $16,500 on a per client basis per 30 days at the Laguna Beach Facility and $8,500 for The Shores facility.
• LKRV announced a 10 day FastTrack Protocol with residential therapy and medical treatment combined designed for busy executives. This unique program will generate $13,000 per client for 10 days of intense treatment.
• By focusing on upscale "boutique" recovery facilities, LKRV's business model lends itself to high operating margins.
• LKRV projects aggressive revenue growth through its acquisition strategy and licensing of leading edge proprietary treatment protocol products and services.
• LKRV announced that its Laguna Beach Recovery Center entered into an agreement to offer proprietary treatment protocols licensed from Hythiam®.
• LKRV announced that Joey Buttafuoco will leverage his worldwide popularity to draw attention to the growing crisis of addiction and its consequences. As the newest host, he and his guests share real-life inspirational stories of triumph over tragedy. Mr. Buttafuoco will also regularly interview leaders in the field of recovery who are discovering keys to help those struggling with addiction.

Headline News Network's "Showbiz Tonight" to Feature New Exclusive TV Interview With Joey Buttafuoco About the LTR Radio Network

Globally Televised Show "The Insider" to Feature Segment With Joey Buttafuoco & Dennis Coder Discussing the LTR Radio Network Today

Let's Talk Recovery CEO and Chairman Dennis Coder to be a Guest on Corporate Strategies Radio Show

Joey Buttafuoco Joins LTR Radio Network

Let's Talk Recovery's Laguna Beach Recovery Center Signs Milestone Agreement With Comprehensive Behavioral Health Management Services Company to Provide Proprietary Treatment Protocols

Opportunity

Recently the stock has been relatively obscure and this has created an excellent environment for venturous investors to accumulate shares of this microcap managed care treatment provider before an influx of prospective shareholders, analysts and expanded media coverage bring heightened awareness to this growing company.

According to the transfer agent, there are approximately 71M shares outstanding of which approximately 53M shares are restricted and held by Directors and Management. Correspondingly, we do not expect to see much if any significant selling pressure for shares until above $0.20 where the majority of shareholders are averaged in. With a share price currently under $0.05, LKRV could prove to be an exceptional opportunity for the aggressive microcap investor.

To learn more about Let's Talk Recovery Click Here.

SmallCapReview feature stock reports are intended to be stock ideas, NOT recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. For continuing coverage of LKRV please sign up for our free newsletter. Information contained in this report was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. For more information see our disclaimer section, a link of which can be found on our web site. This document contains forward-looking statements, particularly as related to the business plans of the Company, within the meaning of Section 27A of the Securities Act of 1933 and Sections 21E of the Securities Exchange Act of 1934, and are subject to the safe harbor created by these sections. Actual results may differ materially from the Company's expectations and estimates. The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country.

Copyright SmallCapReview. All rights reserved. SCR is not a Registered Broker/Dealer or Financial Advisor, nor do we hold ourselves out to be. All materials presented on our web site and individual reports released to the public through this web site, e-mail or any other means of transmission are not to be regarded as investment advice and are only for informative purposes. Before making a purchase or sale of any securities featured on our web site or mentioned in our reports, we strongly encourage and recommend consultation with a registered securities representative. This is not to be construed as a solicitation or recommendation to buy or sell securities. As with any stock, companies we select to profile involve a degree of investment risk and volatility. Particularly Small-Caps and OTC-BB stocks. All investors are cautioned that they may lose all or a portion of their investment if they decide to make a purchase in any of our profiled companies. Past performance of our profiled stocks is not indicative of future results. The accuracy or completeness of the information on our web site or within our reports is only as reliable as the sources they were obtained from. The profile and opinions expressed herein are expressed as of the date the profile is posted on site and are subject to change without notice. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. SCR may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our web site or within our reports. In order to be in full compliance with the Securities Act of 1933, Section 17(b), SCR will disclose in it's disclaimer, what, if any compensation was received for our efforts in researching, presenting and disseminating this information to our subscriber database and featuring the report on the SCR web site. SCR has been compensated eight thousand five hundred dollars by Let's Talk Recovery for its efforts in presenting the LKRV profile on its website and distributing it to its database of subscribers. SCR may decide to purchase or sell shares on a voluntary basis in the open market before, during or after the profiling period of this report.

The Reader should verify all claims and do their own due diligence before investing in any securities mentioned. Investing in small-cap securities is speculative and carries a high degree of risk.

We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission (SEC) at: http://www.sec.gov and/or the National Association of Securities Dealers (NASD) at: http://www.nasd.com. Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.